BioSpace News Archive

Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced the initiation of AAA-SHAPE, the Company’s prospective safety study of the IMPEDE-FX Embolization Plug devices when used for abdominal aortic aneurysm (AAA) sac filling during elective endovascular aneurysm repair (EVAR).

Solos Endoscopy, Inc. is pleased to announce it has completed the compatibility testing of its MammoView product line with The STERIS V-PRO 1 Low Temperature Sterilization System.

Camber Spine, a leading innovator in spine and medical technologies, has named Max Painter its new Global Vice President of Sales and Marketing.

LifeSciences BC is pleased to recognize the recipients of the 22nd Annual LifeSciences BC Awards, presented by FARRIS, at our award event online tomorrow September 17 at 2.00 - 3.30pm. These awards are presented annually to recognize talented individuals and organizations that represent the life sciences ecosystem in B.C. which includes academia, health institutions, research & development, SMEs, governm

Carmel-based PathogenX, a medical device company that develops, manufactures, and distributes proprietary technology designed to dramatically simplify the process of medical waste disposal, has announced a partnership agreement with Toronto-based Invotek Group, Inc. (IGI)

JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, provided an update today regarding its initiatives to pursue a strategic alternative process for its legacy businesses first announced in June 2020.

Amgen (NASDAQ:AMGN) announced today that data from its oncology pipeline in solid tumors will be presented during the European Society of Medical Oncology (ESMO) Virtual Congress 2020, Sept. 19-21, 2020.

DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that the company will be presenting at several upcoming virtual medical meetings.

DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that Clyde R. Hosein has been appointed to its Board of Directors (“Board”), increasing the size of its Board from eleven to twelve members. “We are extremely pleased to welcome Clyde Hosein to our Board,” said Eric K. Brandt, Chairman of Dentsply Sirona. “As we proactively manage our anticipated Director retirements and Board refreshment

- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it intends to offer and sell ordinary shares in an underwritten public offering. The Company also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of o